Citizens Holding (NASDAQ:CIZN) reported quarterly earnings of $0.34 per share. This is a 30.77 percent increase over earnings of $0.26 per share from the same period last year.
Legend Biotech Announced Longer-Term Data from CARTITUDE Program Presented at ASCO Show Overall Response Rate Remains at 98% After More Than Two Years, With Median Progression-free and Overall Survival Not Yet Being Reached
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, presented today new and updated results from the CARTITUDE clinical development program studying ciltacabtagene autoleucel (cilta-cel) in t
